Delphi Diagnostics today announced the publication of findings from the GEICAM/9906 clinical trial demonstrating that the company's Endocrine Activity Index (EAI) can identify patients with hormone ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting ...
The study, which analyzed 659 patient samples from the PACS-01 clinical trial, demonstrates that EAI RR provides meaningful prognostic and endocrine-predictive information beyond the 21-gene ...
HOUSTON, May 19, 2026 /PRNewswire/ -- Delphi Diagnostics today announced the appointment of Eric Lindquist as Chief Financial Officer, effective April 1, 2026. Mr. Lindquist brings decades of ...
Peer-reviewed manuscript demonstrates the Endocrine Activity IndexTM Recurrence Risk (EAIRR) enhances risk stratification beyond Recurrence Score® and is predictive of endocrine therapy benefit ...
Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results